Vincent Meador1, William Jordan, John Zimmermann
1Eli Lilly & Company, Greenfield Laboratories, 2001 East Main Street, Greenfield, IN 46140, USA. meador_vincent_p@lilly.com
Optimizing drug development requires efficient toxicity screening. Implementing in vivo toxicity studies strategically minimizes resource use and animal numbers, accelerating compound selection for successful development.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: